SPP1 and cancer: The differential expression of SPP1 in the tissue and plasma samples [48] and its association with poor prognosis in cancer patients with an advanced disease stage indicated that SPP1 may serve as a valuable prognostic biomarker in different solid tumors [49,50] and a potential target for cancer therapy [27,51].